TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
Pharma Production i Stockholm AB
Closing information (x1000 SEK)
Closing information | 2024/06 | 2023/06 | 2022/06 |
Turnover |
12,379
|
11,957
|
12,195 |
Financial expenses |
0
![]() |
0
|
5 |
Earnings before taxes |
4,697
|
4,668
|
5,582 |
EBITDA |
4,620
|
4,695
|
5,604 |
Total assets |
6,442
|
4,269
|
4,462 |
Current assets |
6,333
|
4,126
|
4,373 |
Current liabilities |
3,491
|
868
|
1,012 |
Equity capital |
2,951
|
3,401
|
3,449 |
- share capital |
100
![]() |
100
![]() |
100 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Solvency |
45.8%
|
79.7%
|
77.3% |
Turnover per employee | |||
Profit as a percentage of turnover |
37.9%
|
39.0%
|
45.8% |
Return on assets (ROA) |
72.9%
|
109.3%
|
125.2% |
Current ratio |
181.4%
|
475.3%
|
432.1% |
Return on equity (ROE) |
159.2%
|
137.3%
|
161.8% |
Change turnover |
422
|
-238
|
-149 |
Change turnover % |
4%
|
-2%
|
-1% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2024/06 | 2023/06 | 2022/06 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.